Esperion to Report Fourth Quarter and Full Year 2022 Financial Results February 21, 2023
Esperion (NASDAQ: ESPR) will announce its fourth quarter and full year 2022 financial results on February 21, 2023, before U.S. market open.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Esperion (NASDAQ: ESPR) will announce its fourth quarter and full year 2022 financial results on February 21, 2023, before U.S. market open. Following the announcement, management will host a webcast and conference call at 8:00 a.m. ET to discuss the results and upcoming milestones. Investors can pre-register for the call and access a live webcast on the company’s investor section. The replay will be available shortly after the call and archived for 90 days. Esperion focuses on developing innovative cholesterol-lowering therapies, aiming to provide solutions for patients with unmet needs.
Details
News Market Reaction – ESPR
The recorded move for ESPR in the trading session of this news was +3.95%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ANN ARBOR, Mich., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced it will report fourth quarter and full year 2022 financial results before the open of the U.S. financial markets on Tuesday, February 21, 2023.
Following the release, company management will host a webcast and conference call at 8:00 a.m. ET to discuss the financial results and upcoming corporate milestones. Please click here to pre-register to participate in the conference call and obtain your dial in number and PIN.
Already registered? Access with your PIN here.
A live webcast can be accessed on the investors and media section of the Esperion website. Access to the webcast replay will be available approximately two hours after completion of the call and will be archived on the Company’s website for approximately 90 days.
Esperion Therapeutics
Esperion works hard to make our medicines easy to get, easy to take, and easy to have. We discover, develop, and commercialize innovative medicines and combinations to lower cholesterol, especially for patients whose needs aren’t being met by the status quo. Our entrepreneurial team of industry leaders is inclusive, passionate and resourceful. We are singularly focused on managing cholesterol so you can improve your health easily. For more information, please visit esperion.com and follow us on Twitter at www.twitter.com/EsperionInc.
Contact:
Esperion Corporate Communications
corporateteam@esperion.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.